When 90% of people say they would prefer a painless patch to a needle, why has no one brought one to market? Everyone assumed it was a science problem. Henry Dunne discovered it was not.

Through intensive customer discovery, Henry and his co-founder learned that microneedle technology works. The patents exist. The science is proven. But previous companies focused on perfecting the patch while ignoring a fundamental barrier: manufacturing cost. When your product costs ten to twenty times more than the needle it replaces, there is no market.

This episode is a masterclass in solving the right problem. Henry shares how getting out of the lab and talking to pharmaceutical companies revealed what academics had missed for decades. He discusses building IP strategy as a student founder, navigating the funding gap in life sciences, and why cel ...